| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.12 | 0.6 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |